Treatment of metastatic spinal lesions with a navigational bipolar radiofrequency ablation device

A multicenter retrospective study

Praveen R. Anchala, Winston D. Irving, Travis J. Hillen, Michael V. Friedman, Bassem A. Georgy, Douglass M. Coldwell, Nam D. Tran, Frank D. Vrionis, Allan L. Brook, Jack W. Jennings

Research output: Contribution to journalArticle

41 Citations (Scopus)

Abstract

Background: Spinal metastatic lesions are a common occurrence among oncology patients and contribute to significant morbidity. Treatment options have been limited in their effectiveness and scope to this point. Objective: This study aims to report the safety and efficacy of radiofrequency ablation (RFA) of malignant spinal lesions using a novel RFA bipolar tumor ablation system which includes a navigational electrode containing 2 active thermocouples. Study Design: IRB approved multicenter retrospective review of patients receiving RFA as a treatment of metastatic osseous lesions between March 2012 and March 2013. Setting: This study consists of patients from 5 large academic centers. Method: One hundred twenty-eight metastatic lesions were identified in 92 patients who underwent a total of 96 procedures. Cement augmentation was performed when the vertebral body was at risk or had a pathological fracture. Visual analogue scale (VAS) scores were obtained preoperatively as well as postoperatively at the one week, one month, and 6 month time points. Interval change in the patients' pain medications was recorded. Postoperative imaging was used to assess tumor burden at the treated level when available. Results: RFA was technically successful in all of the lesions without complication or thermal injury. Our study demonstrated significant (P < 0.01) decreases in the VAS scores at one week, one month, and 6 months postoperatively. In our largest center, 54% of our patients experienced a decrease and 30% had no change in their pain medications postoperatively. Sixtytwo percent of the spinal lesions in this largest institution were located in the posterior vertebral body. Post-ablation imaging confirmed size of ablation zones consistent with that measured by the thermocouples. Limitations: The main limitations of this study are the heterogeneous patient population, data set, and potential confounding variable of concurrent cement augmentation. Conclusion: The STAR System is an RFA device that was safely and effectively used in the treatment of spine metastatic osseous lesions. This new device allows RFA treatment of previously untreatable lesions with resultant reduction in pain that was not controlled by systemic or radiation therapy.

Original languageEnglish (US)
Pages (from-to)317-327
Number of pages11
JournalPain Physician
Volume17
Issue number4
StatePublished - 2014

Fingerprint

Multicenter Studies
Retrospective Studies
Equipment and Supplies
Visual Analog Scale
Pain
Therapeutics
Spontaneous Fractures
Confounding Factors (Epidemiology)
Research Ethics Committees
Tumor Burden
Electrodes
Spine
Radiotherapy
Hot Temperature
Morbidity
Safety
Wounds and Injuries
Population
Neoplasms

Keywords

  • Interventional oncology
  • Oncology
  • Osseous metastasis
  • Pain
  • Pain management
  • Radiofrquency ablation
  • Spine
  • Tumor
  • Vertebral augmentation

ASJC Scopus subject areas

  • Anesthesiology and Pain Medicine

Cite this

Anchala, P. R., Irving, W. D., Hillen, T. J., Friedman, M. V., Georgy, B. A., Coldwell, D. M., ... Jennings, J. W. (2014). Treatment of metastatic spinal lesions with a navigational bipolar radiofrequency ablation device: A multicenter retrospective study. Pain Physician, 17(4), 317-327.

Treatment of metastatic spinal lesions with a navigational bipolar radiofrequency ablation device : A multicenter retrospective study. / Anchala, Praveen R.; Irving, Winston D.; Hillen, Travis J.; Friedman, Michael V.; Georgy, Bassem A.; Coldwell, Douglass M.; Tran, Nam D.; Vrionis, Frank D.; Brook, Allan L.; Jennings, Jack W.

In: Pain Physician, Vol. 17, No. 4, 2014, p. 317-327.

Research output: Contribution to journalArticle

Anchala, PR, Irving, WD, Hillen, TJ, Friedman, MV, Georgy, BA, Coldwell, DM, Tran, ND, Vrionis, FD, Brook, AL & Jennings, JW 2014, 'Treatment of metastatic spinal lesions with a navigational bipolar radiofrequency ablation device: A multicenter retrospective study', Pain Physician, vol. 17, no. 4, pp. 317-327.
Anchala PR, Irving WD, Hillen TJ, Friedman MV, Georgy BA, Coldwell DM et al. Treatment of metastatic spinal lesions with a navigational bipolar radiofrequency ablation device: A multicenter retrospective study. Pain Physician. 2014;17(4):317-327.
Anchala, Praveen R. ; Irving, Winston D. ; Hillen, Travis J. ; Friedman, Michael V. ; Georgy, Bassem A. ; Coldwell, Douglass M. ; Tran, Nam D. ; Vrionis, Frank D. ; Brook, Allan L. ; Jennings, Jack W. / Treatment of metastatic spinal lesions with a navigational bipolar radiofrequency ablation device : A multicenter retrospective study. In: Pain Physician. 2014 ; Vol. 17, No. 4. pp. 317-327.
@article{50c19e22b0a744f1855565797aea2b5b,
title = "Treatment of metastatic spinal lesions with a navigational bipolar radiofrequency ablation device: A multicenter retrospective study",
abstract = "Background: Spinal metastatic lesions are a common occurrence among oncology patients and contribute to significant morbidity. Treatment options have been limited in their effectiveness and scope to this point. Objective: This study aims to report the safety and efficacy of radiofrequency ablation (RFA) of malignant spinal lesions using a novel RFA bipolar tumor ablation system which includes a navigational electrode containing 2 active thermocouples. Study Design: IRB approved multicenter retrospective review of patients receiving RFA as a treatment of metastatic osseous lesions between March 2012 and March 2013. Setting: This study consists of patients from 5 large academic centers. Method: One hundred twenty-eight metastatic lesions were identified in 92 patients who underwent a total of 96 procedures. Cement augmentation was performed when the vertebral body was at risk or had a pathological fracture. Visual analogue scale (VAS) scores were obtained preoperatively as well as postoperatively at the one week, one month, and 6 month time points. Interval change in the patients' pain medications was recorded. Postoperative imaging was used to assess tumor burden at the treated level when available. Results: RFA was technically successful in all of the lesions without complication or thermal injury. Our study demonstrated significant (P < 0.01) decreases in the VAS scores at one week, one month, and 6 months postoperatively. In our largest center, 54{\%} of our patients experienced a decrease and 30{\%} had no change in their pain medications postoperatively. Sixtytwo percent of the spinal lesions in this largest institution were located in the posterior vertebral body. Post-ablation imaging confirmed size of ablation zones consistent with that measured by the thermocouples. Limitations: The main limitations of this study are the heterogeneous patient population, data set, and potential confounding variable of concurrent cement augmentation. Conclusion: The STAR System is an RFA device that was safely and effectively used in the treatment of spine metastatic osseous lesions. This new device allows RFA treatment of previously untreatable lesions with resultant reduction in pain that was not controlled by systemic or radiation therapy.",
keywords = "Interventional oncology, Oncology, Osseous metastasis, Pain, Pain management, Radiofrquency ablation, Spine, Tumor, Vertebral augmentation",
author = "Anchala, {Praveen R.} and Irving, {Winston D.} and Hillen, {Travis J.} and Friedman, {Michael V.} and Georgy, {Bassem A.} and Coldwell, {Douglass M.} and Tran, {Nam D.} and Vrionis, {Frank D.} and Brook, {Allan L.} and Jennings, {Jack W.}",
year = "2014",
language = "English (US)",
volume = "17",
pages = "317--327",
journal = "Pain Physician",
issn = "1533-3159",
publisher = "Association of Pain Management Anesthesiologists",
number = "4",

}

TY - JOUR

T1 - Treatment of metastatic spinal lesions with a navigational bipolar radiofrequency ablation device

T2 - A multicenter retrospective study

AU - Anchala, Praveen R.

AU - Irving, Winston D.

AU - Hillen, Travis J.

AU - Friedman, Michael V.

AU - Georgy, Bassem A.

AU - Coldwell, Douglass M.

AU - Tran, Nam D.

AU - Vrionis, Frank D.

AU - Brook, Allan L.

AU - Jennings, Jack W.

PY - 2014

Y1 - 2014

N2 - Background: Spinal metastatic lesions are a common occurrence among oncology patients and contribute to significant morbidity. Treatment options have been limited in their effectiveness and scope to this point. Objective: This study aims to report the safety and efficacy of radiofrequency ablation (RFA) of malignant spinal lesions using a novel RFA bipolar tumor ablation system which includes a navigational electrode containing 2 active thermocouples. Study Design: IRB approved multicenter retrospective review of patients receiving RFA as a treatment of metastatic osseous lesions between March 2012 and March 2013. Setting: This study consists of patients from 5 large academic centers. Method: One hundred twenty-eight metastatic lesions were identified in 92 patients who underwent a total of 96 procedures. Cement augmentation was performed when the vertebral body was at risk or had a pathological fracture. Visual analogue scale (VAS) scores were obtained preoperatively as well as postoperatively at the one week, one month, and 6 month time points. Interval change in the patients' pain medications was recorded. Postoperative imaging was used to assess tumor burden at the treated level when available. Results: RFA was technically successful in all of the lesions without complication or thermal injury. Our study demonstrated significant (P < 0.01) decreases in the VAS scores at one week, one month, and 6 months postoperatively. In our largest center, 54% of our patients experienced a decrease and 30% had no change in their pain medications postoperatively. Sixtytwo percent of the spinal lesions in this largest institution were located in the posterior vertebral body. Post-ablation imaging confirmed size of ablation zones consistent with that measured by the thermocouples. Limitations: The main limitations of this study are the heterogeneous patient population, data set, and potential confounding variable of concurrent cement augmentation. Conclusion: The STAR System is an RFA device that was safely and effectively used in the treatment of spine metastatic osseous lesions. This new device allows RFA treatment of previously untreatable lesions with resultant reduction in pain that was not controlled by systemic or radiation therapy.

AB - Background: Spinal metastatic lesions are a common occurrence among oncology patients and contribute to significant morbidity. Treatment options have been limited in their effectiveness and scope to this point. Objective: This study aims to report the safety and efficacy of radiofrequency ablation (RFA) of malignant spinal lesions using a novel RFA bipolar tumor ablation system which includes a navigational electrode containing 2 active thermocouples. Study Design: IRB approved multicenter retrospective review of patients receiving RFA as a treatment of metastatic osseous lesions between March 2012 and March 2013. Setting: This study consists of patients from 5 large academic centers. Method: One hundred twenty-eight metastatic lesions were identified in 92 patients who underwent a total of 96 procedures. Cement augmentation was performed when the vertebral body was at risk or had a pathological fracture. Visual analogue scale (VAS) scores were obtained preoperatively as well as postoperatively at the one week, one month, and 6 month time points. Interval change in the patients' pain medications was recorded. Postoperative imaging was used to assess tumor burden at the treated level when available. Results: RFA was technically successful in all of the lesions without complication or thermal injury. Our study demonstrated significant (P < 0.01) decreases in the VAS scores at one week, one month, and 6 months postoperatively. In our largest center, 54% of our patients experienced a decrease and 30% had no change in their pain medications postoperatively. Sixtytwo percent of the spinal lesions in this largest institution were located in the posterior vertebral body. Post-ablation imaging confirmed size of ablation zones consistent with that measured by the thermocouples. Limitations: The main limitations of this study are the heterogeneous patient population, data set, and potential confounding variable of concurrent cement augmentation. Conclusion: The STAR System is an RFA device that was safely and effectively used in the treatment of spine metastatic osseous lesions. This new device allows RFA treatment of previously untreatable lesions with resultant reduction in pain that was not controlled by systemic or radiation therapy.

KW - Interventional oncology

KW - Oncology

KW - Osseous metastasis

KW - Pain

KW - Pain management

KW - Radiofrquency ablation

KW - Spine

KW - Tumor

KW - Vertebral augmentation

UR - http://www.scopus.com/inward/record.url?scp=84904653533&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84904653533&partnerID=8YFLogxK

M3 - Article

VL - 17

SP - 317

EP - 327

JO - Pain Physician

JF - Pain Physician

SN - 1533-3159

IS - 4

ER -